Etkin Amit bought ANRO
February 6, 2024 · Form 4 insider transaction
Etkin Amit bought 11,777 shares of Alto Neuroscience, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
11,777
Price
N/A
Total value
N/A
InsiderEtkin Amit
RoleOfficer, Director
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateFebruary 6, 2024
Filing dateFebruary 7, 2024
Shares owned after1,202,340
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date.